In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...
U.S. President Biden signed a bill last Thursday postponing the sunset date of the rare pediatric disease Priority Review Voucher (PRV) program from September 30, 2024, to December 20, 2024. The bill, ...
Nasdaq provides after-market quotes of stock trades from 4:00 P.M. EST to 8:00 P.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate trading ...
Parnassus Value Select ETF (PRVS) returned 7.04% (NAV) for the quarter, outperforming the Russell 1000 Value Index's 5.33%. In the IT sector, the majority of the Fund's exposure is in semiconductor ...
Short interest in Parnassus Income Funds Parnassus Value Select ETF (NYSE:PRVS) increased during the last reporting period, rising from 688.00 to 2.26K. This put -% of the company's publicly available ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback